Literature DB >> 8183424

The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.

E Scarr1, D M Wingerchuk, A V Juorio, I A Paterson.   

Abstract

The purpose of this study was to examine whether monoamine oxidase type B (MAO-B) has a role in striatal dopamine metabolism in animals with a unilateral lesion of the medial forebrain bundle, and whether 2-phenylethylamine (PE) could have a role in amplification of dopamine (DA) responses in DA depleted striatum. Inhibition of MAO-B did not alter DA metabolism in lesioned striata. PE accumulation decreased with loss of DA as long as there was no DA dysfunction. In lesioned striata with dysfunction of DA transmission at the synaptic level, PE accumulation increased, suggesting a compensatory increase in PE synthesis. This increase in PE levels does not appear to be mediated by an increase in the total striatal aromatic L-amino acid decarboxylase (AADC) activity. We conclude that inhibition of MAO-B has no effect on DA metabolism in the hemi-parkinsonian rat striatum and that PE could be involved in the antiparkinsonian action of MAO-B inhibitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183424     DOI: 10.1007/bf00966810

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain.

Authors:  M Y Zhu; A V Juorio; I A Paterson; A A Boulton
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

3.  High correlations between number of dopamine cells, dopamine levels and motor performance.

Authors:  C Ranje; U Ungerstedt
Journal:  Brain Res       Date:  1977-09-23       Impact factor: 3.252

4.  Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.

Authors:  P Riederer; M B Youdim
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

Review 5.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

6.  Homovanillic acid and dihydroxyphenylacetic acid in the striatum of monkeys with brain lesions.

Authors:  D F Sharman; L J Poirier; G F Murphy; T L Sourkes
Journal:  Can J Physiol Pharmacol       Date:  1967-01       Impact factor: 2.273

7.  A new and highly sensitive voltammetric assay for aromatic L-amino acid decarboxylase activity by high-performance liquid chromatography.

Authors:  T Nagatsu; T Yamamoto; T Kato
Journal:  Anal Biochem       Date:  1979-11-15       Impact factor: 3.365

8.  Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.

Authors:  A V Juorio; I A Paterson; M Y Zhu; G Matte
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

9.  Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.

Authors:  R P Kwok; A V Juorio
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

10.  Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.

Authors:  A J Azzaro; J King; J Kotzuk; D D Schoepp; J Frost; S Schochet
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

View more
  8 in total

1.  Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.

Authors:  O Sader-Mazbar; Y Loboda; M J Rabey; J P M Finberg
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats.

Authors:  A Moser; F Siebecker; F Nobbe; V Böhme
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

Review 3.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 4.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

5.  Modification of L-DOPA pharmacological activity by MAO inhibitors.

Authors:  J P M Finberg; O Sader-Mazbar
Journal:  J Neural Transm (Vienna)       Date:  2007-04-10       Impact factor: 3.575

6.  Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.

Authors:  Agnieszka Ciesielska; Nitasha Sharma; Janine Beyer; John Forsayeth; Krystof Bankiewicz
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 7.  Revisiting the Role of Astrocytic MAOB in Parkinson's Disease.

Authors:  Min-Ho Nam; Moonsun Sa; Yeon Ha Ju; Mingu Gordon Park; C Justin Lee
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

8.  Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis.

Authors:  Hyun-U Cho; Sunpil Kim; Jeongeun Sim; Seulkee Yang; Heeyoung An; Min-Ho Nam; Dong-Pyo Jang; C Justin Lee
Journal:  Exp Mol Med       Date:  2021-07-09       Impact factor: 12.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.